INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 412m ago
HOUSE PTR11m ago
SEC 13F11m ago
ROBINHOOD CHAIN11m ago
Public company

VNRXVOLITIONRX LTD

CIK 0000093314

EDGAR filingsOpen in network
Disclosed transactions3
Buys / sells0 / 0
Max Insider Score21
Connections4with evidence

VNRX · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
21
BL
Batchelor Ann-LouiseGroup Chief Marketing Officer
VNRXVOLITIONRX LTD
Grant or award
A—
12.0K sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2835 · In Vitro & In Vivo Diagnostic Substances · Nov 4, 2026
  • ← Insider ofevidence
    Batchelor Ann-LouiseGroup Chief Marketing Officer · Oct 23, 2026
  • ← Insider ofevidence
    Forterre GaelChief Commercial Officer · Sep 30, 2026
  • ← Insider ofevidence
    Michel GaetanChief Operating Officer · Sep 30, 2026
13
MG
Michel GaetanChief Operating Officer
VNRXVOLITIONRX LTD
Tax withholding
F
$154
608 sh
Sep 28, 2026
Sep 30, 2026
traded Sep 28, 2026
+2d
SEC FORM 4

Evidence

9
FG
Forterre GaelChief Commercial Officer
VNRXVOLITIONRX LTD
Tax withholding
F$71.82
284 sh
Sep 28, 2026Sep 30, 2026
traded Sep 28, 2026
+2dSEC FORM 4

Evidence